Exodus Point Capital Management, LP Point Biopharma Global Inc. Transaction History

Exodus Point Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$6.86 - $10.86 $116,716 - $184,772	17,014 New	17,014 $154,000
Q2 2022 Aug 19, 2022	SELL	$5.6 - $9.5 $1.35 Million - $2.28 Million	-240,515 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$5.46 - $8.13 $466,726 - $694,960	85,481 Added 55.14%	240,515 $1.92 Million
Q4 2021 Feb 11, 2022	BUY	$4.83 - $9.75 $748,814 - $1.51 Million	155,034 New	155,034 $868,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.